Patients researching Epclusa cost are often looking for ways to better manage out-of-pocket expenses. ProviderX helps eligible patients coordinate access to Epclusa (sofosbuvir/velpatasvir) through licensed pharmacies in Tijuana, Mexico, using a structured cross-border prescription program.
Based on recent cross-border quotes, many patients report meaningful Epclusa cost savings compared to typical U.S. cash pharmacy prices. Savings vary depending on prescription details, treatment duration, availability, and pharmacy partner.
Savings are estimates only. Final costs depend on prescription details, pharmacy, and availability. ProviderX does not prescribe medications, operate a pharmacy, or ship medications into the United States.
*Example medication packaging from licensed providers in Tijuana.
Epclusa is a specialty prescription medication, which often requires additional coordination compared to standard prescriptions. Below is a clear, step-by-step overview of how access is coordinated through ProviderX.
Upload your valid U.S. prescription for Epclusa through our HIPAA-secure form. We only work with prescriptions issued by licensed U.S. healthcare providers.
Once eligibility is confirmed, our team coordinates the logistics required for your visit to Tijuana and prepares the medication pickup with licensed pharmacy partners.
You will visit licensed pharmacies in Tijuana where Epclusa is prepared and made available in accordance with international regulatory standards.
Pick up your medication in person and return home the same day, with guidance and coordination support throughout the process.
What Epclusa is
Epclusa (sofosbuvir/velpatasvir) is a prescription medication that combines two direct-acting antiviral agents. It is manufactured by Gilead Sciences and is available only with a valid prescription.
Approved medical uses (factual)
According to official prescribing information, Epclusa is approved for the treatment of chronic hepatitis C virus (HCV) infection in adults and pediatric patients (as specified in labeling), across genotypes 1–6, including patients with or without compensated cirrhosis. Use in certain patients with decompensated cirrhosis is defined by the approved labeling and combination requirements.
Important medical notice
This information is provided for educational purposes only. ProviderX does not provide medical care, prescribe medications, or offer treatment recommendations. Decisions regarding Epclusa should be made by a licensed healthcare provider familiar with the patient’s medical history.
Fermentum tincidunt laoreet donec
Fermentum tincidunt laoreet donec
Nisl adipiscing leo id magna egestas eget dapibus enim et. Massa non scelerisque porttitor.
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
R
S
T
V
X
